<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Sun T</submitter><funding>the National Natural Science Foundation of China</funding><pagination>e150833</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8663567</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>6(21)</volume><pubmed_abstract>MALAT1-associated small cytoplasmic RNA (mascRNA) is a highly conserved transfer RNA-like (tRNA-like) noncoding RNA whose function remains largely unknown. We show here that this small RNA molecule played a role in the stringent control of TLR-mediated innate immune responses. mascRNA inhibited activation of NF-κB and mitogen-activated protein kinase (MAPK) signaling and the production of inflammatory cytokines in macrophages stimulated with LPS, a TLR4 ligand. Furthermore, exogenous mascRNA alleviated LPS-induced lung inflammation. However, mascRNA potentiated the phosphorylation of IRF3 and STAT1 and the transcription of IFN-related genes in response to the TLR3 ligand poly(I:C) both in vitro and in vivo. Mechanistically, mascRNA was found to enhance K48-linked ubiquitination and proteasomal degradation of TRAF6, thereby negatively regulating TLR-mediated MyD88-dependent proinflammatory signaling while positively regulating TRIF-dependent IFN signaling. Additionally, heterogeneous nuclear ribonucleoprotein H (hnRNP H) and hnRNP F were found to interact with mascRNA, promote its degradation, and contribute to the fine-tuning of TLR-triggered immune responses. Taken together, our data identify a dual role of mascRNA in both negative and positive regulation of innate immune responses.</pubmed_abstract><journal>JCI insight</journal><pubmed_title>The small RNA mascRNA differentially regulates TLR-induced proinflammatory and antiviral responses.</pubmed_title><pmcid>PMC8663567</pmcid><funding_grant_id>81772308</funding_grant_id><pubmed_authors>Hu Y</pubmed_authors><pubmed_authors>Wei C</pubmed_authors><pubmed_authors>Wang D</pubmed_authors><pubmed_authors>Sun T</pubmed_authors><pubmed_authors>Mao X</pubmed_authors><pubmed_authors>Wang X</pubmed_authors><pubmed_authors>Wang J</pubmed_authors></additional><is_claimable>false</is_claimable><name>The small RNA mascRNA differentially regulates TLR-induced proinflammatory and antiviral responses.</name><description>MALAT1-associated small cytoplasmic RNA (mascRNA) is a highly conserved transfer RNA-like (tRNA-like) noncoding RNA whose function remains largely unknown. We show here that this small RNA molecule played a role in the stringent control of TLR-mediated innate immune responses. mascRNA inhibited activation of NF-κB and mitogen-activated protein kinase (MAPK) signaling and the production of inflammatory cytokines in macrophages stimulated with LPS, a TLR4 ligand. Furthermore, exogenous mascRNA alleviated LPS-induced lung inflammation. However, mascRNA potentiated the phosphorylation of IRF3 and STAT1 and the transcription of IFN-related genes in response to the TLR3 ligand poly(I:C) both in vitro and in vivo. Mechanistically, mascRNA was found to enhance K48-linked ubiquitination and proteasomal degradation of TRAF6, thereby negatively regulating TLR-mediated MyD88-dependent proinflammatory signaling while positively regulating TRIF-dependent IFN signaling. Additionally, heterogeneous nuclear ribonucleoprotein H (hnRNP H) and hnRNP F were found to interact with mascRNA, promote its degradation, and contribute to the fine-tuning of TLR-triggered immune responses. Taken together, our data identify a dual role of mascRNA in both negative and positive regulation of innate immune responses.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Nov</publication><modification>2024-11-10T00:13:42.228Z</modification><creation>2022-02-11T14:56:22.368Z</creation></dates><accession>S-EPMC8663567</accession><cross_references><pubmed>34582376</pubmed><doi>10.1172/jci.insight.150833</doi></cross_references></HashMap>